// App-Quantinova.ai

5160 : Establishment of in vitro carcinogenic model of high-grade serous ovarian carcinoma using immortalized fallopian tubal secretory epithelial cell

Researchers

Presenter

  • Kohei Nakamura

Principal Investigators

  • Kentaro Nakayama

  • Tohru Kiyono

  • Noriyoshi Ishikawa

  • Masako Ishikawa

  • Hiroshi Katagiri

  • Toshiko Minamoto

  • Tomoka Ishibashi

  • Emi Sato

  • Kaori Sanuki

  • Hitomi Yamashita

  • Kouji Iida

  • Razia Sultana

  • Satoru Kyo

Medical Centers

  • Shimane University Faculty of Medicine, Izumo city, Japan.

  • National Cancer Center Research Institute, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • High grade serous ovarian cancer

  • Gynaecological cancer

  • Ovarian cancer

  • High-grade serous carcinoma

  • Solid malignancies

Biomarkers

  • p53

  • cMYC

  • KRAS proto-oncogene, GTPase

  • Telomerase reverse transcriptase

  • PI3K/AKT

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A